Literature DB >> 27238637

Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production.

Paul M Titchenell1, William J Quinn1, Mingjian Lu1, Qingwei Chu1, Wenyun Lu2, Changhong Li3, Helen Chen1, Bobby R Monks1, Julia Chen1, Joshua D Rabinowitz2, Morris J Birnbaum4.   

Abstract

During insulin-resistant states such as type II diabetes mellitus (T2DM), insulin fails to suppress hepatic glucose production (HGP) yet promotes lipid synthesis. This metabolic state has been termed "selective insulin resistance" to indicate a defect in one arm of the insulin-signaling cascade, potentially downstream of Akt. Here we demonstrate that Akt-dependent activation of mTORC1 and inhibition of Foxo1 are required and sufficient for de novo lipogenesis, suggesting that hepatic insulin signaling is likely to be intact in insulin-resistant states. Moreover, cell-nonautonomous suppression of HGP by insulin depends on a reduction of adipocyte lipolysis and serum FFAs but is independent of vagal efferents or glucagon signaling. These data are consistent with a model in which, during T2DM, intact liver insulin signaling drives enhanced lipogenesis while excess circulating FFAs become a dominant inducer of nonsuppressible HGP.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27238637      PMCID: PMC4909537          DOI: 10.1016/j.cmet.2016.04.022

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  51 in total

Review 1.  Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover.

Authors:  Roger H Unger; Alan D Cherrington
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

2.  Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes.

Authors:  Rachel J Perry; João-Paulo G Camporez; Romy Kursawe; Paul M Titchenell; Dongyan Zhang; Curtis J Perry; Michael J Jurczak; Abulizi Abudukadier; Myoung Sook Han; Xian-Man Zhang; Hai-Bin Ruan; Xiaoyong Yang; Sonia Caprio; Susan M Kaech; Hei Sook Sul; Morris J Birnbaum; Roger J Davis; Gary W Cline; Kitt Falk Petersen; Gerald I Shulman
Journal:  Cell       Date:  2015-02-05       Impact factor: 41.582

Review 3.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

4.  Hypothalamic K(ATP) channels control hepatic glucose production.

Authors:  Alessandro Pocai; Tony K T Lam; Roger Gutierrez-Juarez; Silvana Obici; Gary J Schwartz; Joseph Bryan; Lydia Aguilar-Bryan; Luciano Rossetti
Journal:  Nature       Date:  2005-04-21       Impact factor: 49.962

5.  FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.

Authors:  InSug O-Sullivan; Wenwei Zhang; David H Wasserman; Chong Wee Liew; Jonathan Liu; Jihye Paik; Ronald A DePinho; Donna Beer Stolz; C Ronald Kahn; Michael W Schwartz; Terry G Unterman
Journal:  Nat Commun       Date:  2015-05-12       Impact factor: 14.919

6.  FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression.

Authors:  Wenwei Zhang; Sandip Patil; Balwant Chauhan; Shaodong Guo; David R Powell; Jamie Le; Angelos Klotsas; Ryan Matika; Xiangshan Xiao; Roberta Franks; Kim A Heidenreich; Mini P Sajan; Robert V Farese; Donna Beer Stolz; Patrick Tso; Seung-Hoi Koo; Marc Montminy; Terry G Unterman
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

7.  PKC-theta knockout mice are protected from fat-induced insulin resistance.

Authors:  Jason K Kim; Jonathan J Fillmore; Mary Jean Sunshine; Bjoern Albrecht; Takamasa Higashimori; Dong-Wook Kim; Zhen-Xiang Liu; Timothy J Soos; Gary W Cline; William R O'Brien; Dan R Littman; Gerald I Shulman
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

8.  Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin.

Authors:  K Rebrin; G M Steil; L Getty; R N Bergman
Journal:  Diabetes       Date:  1995-09       Impact factor: 9.461

9.  Deletion of hepatic FoxO1/3/4 genes in mice significantly impacts on glucose metabolism through downregulation of gluconeogenesis and upregulation of glycolysis.

Authors:  Xiwen Xiong; Rongya Tao; Ronald A DePinho; X Charlie Dong
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

10.  SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth.

Authors:  Thomas Porstmann; Claudio R Santos; Beatrice Griffiths; Megan Cully; Mary Wu; Sally Leevers; John R Griffiths; Yuen-Li Chung; Almut Schulze
Journal:  Cell Metab       Date:  2008-09       Impact factor: 27.287

View more
  106 in total

Review 1.  Hepatic Insulin Clearance: Mechanism and Physiology.

Authors:  Sonia M Najjar; Germán Perdomo
Journal:  Physiology (Bethesda)       Date:  2019-05-01

2.  A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase ROP18.

Authors:  Zhaoshou Yang; Yongheng Hou; Taofang Hao; Hee-Sool Rho; Jun Wan; Yizhao Luan; Xin Gao; Jianping Yao; Aihua Pan; Zhi Xie; Jiang Qian; Wanqin Liao; Heng Zhu; Xingwang Zhou
Journal:  Mol Cell Proteomics       Date:  2017-01-13       Impact factor: 5.911

3.  Mitochondrial CoQ deficiency is a common driver of mitochondrial oxidants and insulin resistance.

Authors:  Roland Stocker; David E James; Daniel J Fazakerley; Rima Chaudhuri; Pengyi Yang; Ghassan J Maghzal; Kristen C Thomas; James R Krycer; Sean J Humphrey; Benjamin L Parker; Kelsey H Fisher-Wellman; Christopher C Meoli; Nolan J Hoffman; Ciana Diskin; James G Burchfield; Mark J Cowley; Warren Kaplan; Zora Modrusan; Ganesh Kolumam; Jean Yh Yang; Daniel L Chen; Dorit Samocha-Bonet; Jerry R Greenfield; Kyle L Hoehn
Journal:  Elife       Date:  2018-02-06       Impact factor: 8.140

4.  Adipocyte JAK2 mediates growth hormone-induced hepatic insulin resistance.

Authors:  Kevin C Corbit; João Paulo G Camporez; Jennifer L Tran; Camella G Wilson; Dylan A Lowe; Sarah M Nordstrom; Kirthana Ganeshan; Rachel J Perry; Gerald I Shulman; Michael J Jurczak; Ethan J Weiss
Journal:  JCI Insight       Date:  2017-02-09

5.  FoxO1 Is Required for Most of the Metabolic and Hormonal Perturbations Produced by Hepatic Insulin Receptor Deletion in Male Mice.

Authors:  Alisha V Ling; Mary E Gearing; Ivana Semova; Dong-Ju Shin; Rebecca Clements; Zon W Lai; Sudha B Biddinger
Journal:  Endocrinology       Date:  2018-03-01       Impact factor: 4.736

Review 6.  Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics.

Authors:  Alexander Yang; Emilio P Mottillo
Journal:  Biochem J       Date:  2020-03-13       Impact factor: 3.857

7.  Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.

Authors:  Dale S Edgerton; Melanie Scott; Ben Farmer; Phillip E Williams; Peter Madsen; Thomas Kjeldsen; Christian L Brand; Christian Fledelius; Erica Nishimura; Alan D Cherrington
Journal:  JCI Insight       Date:  2019-02-26

Review 8.  Metabolic Vascular Syndrome: New Insights into a Multidimensional Network of Risk Factors and Diseases.

Authors:  Gerhard H Scholz; Markolf Hanefeld
Journal:  Visc Med       Date:  2016-10-07

Review 9.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

10.  ChREBP regulates fructose-induced glucose production independently of insulin signaling.

Authors:  Mi-Sung Kim; Sarah A Krawczyk; Ludivine Doridot; Alan J Fowler; Jennifer X Wang; Sunia A Trauger; Hye-Lim Noh; Hee Joon Kang; John K Meissen; Matthew Blatnik; Jason K Kim; Michelle Lai; Mark A Herman
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.